Oxford BioMedica PLC (OXB) — Cash Flow Quality Index
Latest as of December 2021:
2.53x
Oxford BioMedica PLC (OXB) has a Cash Flow Quality Index of 2.53x as of December 2021. Operating cash flow of GBX2.38 Million exceeds net income of GBX942.00K, indicating high earnings quality where cash backs reported profits. Explore OXB operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
2.53x
Operating CF / Net Income
Operating Cash Flow
GBX2.38 Million
GBX
Net Income
GBX942.00K
GBX
Data as of
Dec 2021
Most recent filing
Oxford BioMedica PLC Cash Flow Quality Index (2018–2021)
Historical Cash Flow Quality Index for Oxford BioMedica PLC across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see OXB cash flow metrics.
Annual Cash Flow Quality Index for Oxford BioMedica PLC (2018–2021)
Year-by-year earnings quality comparison for Oxford BioMedica PLC.
| Year | Quality Index | Operating CF (GBX) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 1.28x | GBX25.45 Million | GBX19.88 Million | ▲ +38.5% |
| 2018 | 0.92x | GBX12.87 Million | GBX13.91 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.